Transition Metal-based Nanoparticles As Potential Antimicrobial Agents: Recent Advancements, Mechanistic, Challenges, and Future Prospects

Overview

Journal Discov Nano

Date 2023 Jun 29

PMID 37382784

Authors

Sonali Gautam

Dipak Kumar Das

Jasvinder Kaur

Anuj Kumar

Mohd Ubaidullah

Mudassir Hasan

Krishna Kumar Yadav

Ram K Gupta

Affiliations

Soon will be listed here.

Abstract

Bacterial transmission is considered one of the potential risks for communicable diseases, requiring promising antibiotics. Traditional drugs possess a limited spectrum of effectiveness, and their frequent administration reduces effectiveness and develops resistivity. In such a situation, we are left with the option of developing novel antibiotics with higher efficiency. In this regard, nanoparticles (NPs) may play a pivotal role in managing such medical situations due to their distinct physiochemical characteristics and impressive biocompatibility. Metallic NPs are found to possess extraordinary antibacterial effects that are useful in vitro as well as in vivo as self-modified therapeutic agents. Due to their wide range of antibacterial efficacy, they have potential therapeutic applications via diverse antibacterial routes. NPs not only restrict the development of bacterial resistance, but they also broaden the scope of antibacterial action without binding the bacterial cell directly to a particular receptor with promising effectiveness against both Gram-positive and Gram-negative microbes. This review aimed at exploring the most relevant types of metal NPs employed as antimicrobial agents, particularly those based on Mn, Fe, Co, Cu, and Zn metals, and their antimicrobial mechanisms. Further, the challenges and future prospects of NPs in biological applications are also discussed.

Citing Articles

FeO@SiO/Schiff-base/Zn (II) nanocomposite functioning as a versatile antimicrobial agent against bacterial and fungal pathogens.

Azadi S, Amani A, Jangjou A, Vaez A, Zareshahrabadi Z, Zare A Sci Rep. 2025; 15(1):5694.

PMID: 39962153 PMC: 11833134. DOI: 10.1038/s41598-025-86518-6.

Antimicrobial Feature of Nanoparticles in the Antibiotic Resistance Era: From Mechanism to Application.

Salmani-Zarchi H, Mousavi-Sagharchi S, Sepahdoost N, Ranjbar-Jamalabadi M, Gross J, Jooya H Adv Biomed Res. 2024; 13:113.

PMID: 39717242 PMC: 11665187. DOI: 10.4103/abr.abr_92_24.

Potential role of metal nanoparticles in treatment of peri-implant mucositis and peri-implantitis.

Hosseini Hooshiar M, Mozaffari A, Ahmed M, Kareem R, Jaber Zrzo A, Mansoor A Biomed Eng Online. 2024; 23(1):101.

PMID: 39396020 PMC: 11470642. DOI: 10.1186/s12938-024-01294-0.

Nail Lacquer Containing and Essential Oils and Biogenic Silver Nanoparticles for Onychomycosis: Development, Characterization, and Evaluation of Antifungal Efficacy.

Scandorieiro S, de Oliveira N, de Souza M, de Castro-Hoshino L, Baesso M, Nakazato G Antibiotics (Basel). 2024; 13(9).

PMID: 39335065 PMC: 11428305. DOI: 10.3390/antibiotics13090892.

Metallic nano-warriors: Innovations in nanoparticle-based ocular antimicrobials.

Zhang M, Cheng Y, Li H, Li M, Yang Q, Hua K Mater Today Bio. 2024; 28:101242.

PMID: 39315395 PMC: 11419815. DOI: 10.1016/j.mtbio.2024.101242.

References

Souri M, Hoseinpour V, Shakeri A, Ghaemi N . Optimisation of green synthesis of MnO nanoparticles via utilising response surface methodology. IET Nanobiotechnol. 2018; 12(6):822-827. PMC: 8676278. DOI: 10.1049/iet-nbt.2017.0145. View

Chandekar K, Shkir M, AlShahrani T, Ibrahim E, Kilany M, Ahmad Z . One-spot fabrication and in-vivo toxicity evaluation of core-shell magnetic nanoparticles. Mater Sci Eng C Mater Biol Appl. 2021; 122:111898. DOI: 10.1016/j.msec.2021.111898. View

Li Y, Zhang W, Niu J, Chen Y . Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano. 2012; 6(6):5164-73. DOI: 10.1021/nn300934k. View

Ewald D, Sumner S . Human microbiota, blood group antigens, and disease. Wiley Interdiscip Rev Syst Biol Med. 2018; 10(3):e1413. PMC: 5902424. DOI: 10.1002/wsbm.1413. View

Padmavathy N, Vijayaraghavan R . Interaction of ZnO nanoparticles with microbes--a physio and biochemical assay. J Biomed Nanotechnol. 2012; 7(6):813-22. DOI: 10.1166/jbn.2011.1343. View

Hyldgaard M, Mygind T, Vad B, Stenvang M, Otzen D, Meyer R . The antimicrobial mechanism of action of epsilon-poly-l-lysine. Appl Environ Microbiol. 2014; 80(24):7758-70. PMC: 4249222. DOI: 10.1128/AEM.02204-14. View

Phillips I, Casewell M, Cox T, De Groot B, Friis C, Jones R . Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother. 2003; 53(1):28-52. DOI: 10.1093/jac/dkg483. View

Popescu T, Matei C, Vlaicu I, Tivig I, Kuncser A, Stefan M . Influence of surfactant-tailored Mn-doped ZnO nanoparticles on ROS production and DNA damage induced in murine fibroblast cells. Sci Rep. 2020; 10(1):18062. PMC: 7582184. DOI: 10.1038/s41598-020-74816-0. View

Zhang S, Gao H, Bao G . Physical Principles of Nanoparticle Cellular Endocytosis. ACS Nano. 2015; 9(9):8655-71. PMC: 5681865. DOI: 10.1021/acsnano.5b03184. View

10.

Azizi-Lalabadi M, Ehsani A, Divband B, Alizadeh-Sani M . Antimicrobial activity of Titanium dioxide and Zinc oxide nanoparticles supported in 4A zeolite and evaluation the morphological characteristic. Sci Rep. 2019; 9(1):17439. PMC: 6877518. DOI: 10.1038/s41598-019-54025-0. View

11.

Singh A, Gautam P, Verma A, Singh V, Shivapriya P, Shivalkar S . Green synthesis of metallic nanoparticles as effective alternatives to treat antibiotics resistant bacterial infections: A review. Biotechnol Rep (Amst). 2020; 25:e00427. PMC: 7005563. DOI: 10.1016/j.btre.2020.e00427. View

12.

Khan S, Shahid S, Shahid B, Fatima U, Abbasi S . Green Synthesis of MnO Nanoparticles Using Leaf Extract for Biological, Photocatalytic, and Adsorption Activities. Biomolecules. 2020; 10(5). PMC: 7277848. DOI: 10.3390/biom10050785. View

13.

Ben-Sasson M, Zodrow K, Genggeng Q, Kang Y, Giannelis E, Elimelech M . Surface functionalization of thin-film composite membranes with copper nanoparticles for antimicrobial surface properties. Environ Sci Technol. 2013; 48(1):384-93. DOI: 10.1021/es404232s. View

14.

Akbarzadeh F, Motaghi M, Chauhan N, Sargazi G . A novel synthesis of new antibacterial nanostructures based on Zn-MOF compound: design, characterization and a high performance application. Heliyon. 2020; 6(1):e03231. PMC: 6994313. DOI: 10.1016/j.heliyon.2020.e03231. View

15.

Pelgrift R, Friedman A . Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013; 65(13-14):1803-15. DOI: 10.1016/j.addr.2013.07.011. View

16.

Berini F, Orlandi V, Gornati R, Bernardini G, Marinelli F . Nanoantibiotics to fight multidrug resistant infections by Gram-positive bacteria: hope or reality?. Biotechnol Adv. 2022; 57:107948. DOI: 10.1016/j.biotechadv.2022.107948. View

17.

Pan X, Wang Y, Chen Z, Pan D, Cheng Y, Liu Z . Investigation of antibacterial activity and related mechanism of a series of nano-Mg(OH)₂. ACS Appl Mater Interfaces. 2013; 5(3):1137-42. DOI: 10.1021/am302910q. View

18.

Anwar A, Numan A, Siddiqui R, Khalid M, Khan N . Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii. Parasit Vectors. 2019; 12(1):280. PMC: 6545699. DOI: 10.1186/s13071-019-3528-2. View

19.

Frei A, Verderosa A, Elliott A, Zuegg J, Blaskovich M . Metals to combat antimicrobial resistance. Nat Rev Chem. 2023; 7(3):202-224. PMC: 9907218. DOI: 10.1038/s41570-023-00463-4. View

20.

Lesniak A, Salvati A, Santos-Martinez M, Radomski M, Dawson K, Aberg C . Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc. 2013; 135(4):1438-44. DOI: 10.1021/ja309812z. View